Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 2, 2012, Pages 131-136

  Walter, Franziska ^a,b   Czernin, Johannes ^a,b   Hall, Theodore ^a   Allen Auerbach, Martin ^a,b   Walter, Martin A ^c   Dunkelmann, Simone ^d   Federman, Noah ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ahmanson Translational Imaging Division   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^e MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

bone scan; FDG PET CT; pediatric population; sarcoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M;

ADOLESCENT; ARTICLE; BONE BIOPSY; BONE LESION; BONE METASTASIS; BONE RESECTION; BONE SCINTISCANNING; CANCER DIAGNOSIS; CHILD; CHILD CARE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EWING SARCOMA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MALE; OSTEOSARCOMA; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOMA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; WHOLE BODY PET;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIONUCLIDE IMAGING; RETROSPECTIVE STUDIES; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M MEDRONATE;

EID: 84857913963     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182282825     Document Type: Article

References (26)

1. Mettler FA Jr, Huda W, Yoshizumi TT, et al. Effective doses in radiology and diagnostic nuclear medicine: A catalog. Radiology. 2008;248:254-263.
2. Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med. 2009;361:849-857.
3. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007;357: 2277-2284.
4. Chawla SC, Federman N, Zhang D, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: A 5-year retrospective review. Pediatr Radiol. 2010;40:681-686.
5. Heare T, Hensley MA, Dell'Orfano S. Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr. 2009;21: 365-372.
6. Meyer WH, Spunt SL. Soft tissue sarcomas of childhood. Cancer Treat Rev. 2004;30:269-280.
7. Hayes-Jordan A, Andrassy R. Rhabdomyosarcoma in children. Curr Opin Pediatr. 2009;21:373-378.
8. Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and highdose methotrexate. J Clin Oncol. 2005;23:2004-2011.
9. Bernstein M, Kovar H, Paulussen M, et al. Ewing's sarcoma family of tumors: Current management. Oncologist. 2006; 11:503-519.
10. Krishnan K, Khanna C, Helman LJ. The biology of metastases in pediatric sarcomas. Cancer J. 2005;11:306-313.
11. Iagaru A, Quon A, McDougall IR, et al. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clin Nucl Med. 2006;31:754-760.
12. Volker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial. J Clin Oncol. 2007;25:5435-5441.
13. Arush MW, Israel O, Postovsky S, et al. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer. 2007;49:901-905.
14. Tateishi U, Hosono A, Makimoto A, et al. Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas. J Pediatr Hematol Oncol. 2007;29:608-612.
15. Mody RJ, Bui C, Hutchinson RJ, et al. FDG PET imaging of childhood sarcomas. Pediatr Blood Cancer. 2010;54:222-227.
16. Meyer JS, Nadel HR, Marina N, et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2008;51:163-170.
17. Franzius C, Sciuk J, Daldrup-Link HE, et al. FDG-PET for detection of osseous metastases from malignant primary bone tumours: Comparison with bone scintigraphy. Eur J Nucl Med. 2000;27:1305-1311.
18. McCarville MB, Christie R, Daw NC, et al. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol. 2005;184:1293-1304.
19. Allen-Auerbach M, Yeom K, Park J, et al. Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. J Nucl Med. 2006; 47:298-301.
20. Halpern BS, Dahlbom M, Quon A, et al. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med. 2004;45:797-801.
21. Robbins E. Radiation risks from imaging studies in children with cancer. Pediatr Blood Cancer. 2008;51:453-457.
22. Hall EJ. Radiation biology for pediatric radiologists. Pediatr Radiol. 2009;39(Suppl 1):S57-S64.
23. Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008;100:428-436.
24. Gelfand MJ. Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients. Pediatr Radiol. 2009;39(Suppl 1):S46-S56.
25. Fahey FH. Dosimetry of Pediatric PET/CT. J Nucl Med. 2009;50:1483-1491.
26. Strauss KJ, Goske MJ, Kaste SC, et al. Image gently: Ten steps you can take to optimize image quality and lower CT dose for pediatric patients. AJR Am J Roentgenol. 2010;194: 868-873.